Who’s in charge of psilocybin?
We’re in the middle of a psychedelic turf war. With psychedelic medicine on the cusp of going mainstream, an increasing number of players are vying for narrative control. From clinicians and investors to Indigenous groups and activists, debate is raging over whether psychedelics are spiritual tools, new psychiatric drugs, medicines for social change, or all of the above. This battle for control is not only unnecessary, but blinds us to a unique opportunity.